Revisiting risk stratification in hypertrophic cardiomyopathy: do we need to start from scratch?

PubWeight™: 0.77‹?›

🔗 View Article (PMID 22019864)

Published in Heart Rhythm on October 20, 2011

Authors

Ming-Sum Lee, Calum A Macrae

Articles citing this

Genetic testing in cardiovascular diseases. Curr Opin Cardiol (2014) 0.88

Mendelian forms of structural cardiovascular disease. Curr Cardiol Rep (2013) 0.75

Articles by these authors

Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature (2010) 6.69

Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol (2010) 2.87

The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion. Development (2011) 2.11

Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation. Heart Rhythm (2009) 1.87

Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet (2005) 1.80

AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development (2008) 1.44

Wnt11 patterns a myocardial electrical gradient through regulation of the L-type Ca(2+) channel. Nature (2010) 1.40

Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. J Am Coll Cardiol (2005) 1.32

Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26

Systematic approaches to toxicology in the zebrafish. Annu Rev Pharmacol Toxicol (2011) 1.25

Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol (2005) 1.23

Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol (2005) 1.12

Cdk5, a therapeutic target for Alzheimer's disease? Biochim Biophys Acta (2004) 1.07

An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential. Circulation (2013) 1.06

Reduced apelin levels in lone atrial fibrillation. Eur Heart J (2005) 0.97

Chondroitin sulfate expression is required for cardiac atrioventricular canal formation. Dev Dyn (2009) 0.95

Zebrafish genetic models for arrhythmia. Prog Biophys Mol Biol (2009) 0.93

The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heart. Prog Biophys Mol Biol (2012) 0.92

Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol (2013) 0.91

GC box-binding transcription factors control the neuronal specific transcription of the cyclin-dependent kinase 5 regulator p35. J Biol Chem (2001) 0.89

The genetics of atrial fibrillation. J Cardiovasc Electrophysiol (2003) 0.88

Hadp1, a newly identified pleckstrin homology domain protein, is required for cardiac contractility in zebrafish. Dis Model Mech (2011) 0.85

An in vivo zebrafish screen identifies organophosphate antidotes with diverse mechanisms of action. J Biomol Screen (2012) 0.83

Splicing and dilated cardiomyopathy one gene to rule them all? J Am Coll Cardiol (2009) 0.83

The developmental basis of adult arrhythmia: atrial fibrillation as a paradigm. Front Physiol (2013) 0.82

Distinct troponin C isoform requirements in cardiac and skeletal muscle. Dev Dyn (2010) 0.81

miR-21 represses Pdcd4 during cardiac valvulogenesis. Development (2013) 0.81

Long QT syndrome. Circulation (2014) 0.80

Association of the long QT syndrome With goiter and deafness. Am J Cardiol (2010) 0.77

Optical mapping in the developing zebrafish heart. Pediatr Cardiol (2012) 0.77

Changing the Scale and Efficiency of Chemical Warfare Countermeasure Discovery Using the Zebrafish. Drug Discov Today Dis Models (2013) 0.75

Mutations in desmosomal protein genes and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm (2009) 0.75

Genetics of atrial fibrillation. Future Cardiol (2006) 0.75